Phenobarbital for Alcohol Withdrawal Syndrome (PAWS): You Can Teach an Old Dog New Tricks

Author(s): Heather J Roppel, MSN, APRN-BC, AGACNP, CCNS, CCRN, CNRN; Donna J Schweitzer, MSN, CCNS,CCRN

Contact Hours 1.25

CERP A 1.25

Pharmacology Hours 0.75

Expires Dec 31, 2027

Topics: Pharmacology, Behavioral/Psychosocial

Population: Adult

Role: Staff

Fees
Member: Free
NonMember: $10.00

Added to Collection

Activity Summary

The rise of alcohol use disorder (AUD) correlates with a potential increase in alcohol withdrawal syndrome (AWS) in the hospital. Nurses and APRNs can positively impact the recovery of high-risk patients by identifying and managing AWS early in the patient’s hospital stay. The use of phenobarbital (PHB) is emerging as a foundational treatment option for patients with AWS. During this session, facilitators offer participants real-life examples with two different PHB for AWS (PAWS) protocols which can be used across all continuums of hospital care. We may even throw you a bone.

Objectives

  • Summarize screening and assessment tools to identify high-risk patients for alcohol withdrawal syndrome (AWS).
  • Outline current clinical practice guidelines to treat AWS.
  • Compare management of AWS utilizing phenobarbital protocols versus standard benzodiazepine and adjunct therapy.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.